Abstract

Zinc deficiency can cause a variety of symptoms, including anemia, taste disorders, and hair loss. Due to its antioxidant properties, the link between zinc deficiency and cancer has received a lot of attention recently. Only a small number of studies have looked at the connection between zinc and gynecologic cancers; no studies have looked at the serum zinc status at the time of gynecologic cancer's development or the association between zinc and cancer recurrence. This study's objectives were to clarify the dynamics of serum zinc, identify the associated determinants, and determine whether serum zinc concentrations are related to the development and recurrence of gynecologic cancer. As a result, we retrospectively assessed serum zinc concentrations before treatment in gynecologic patients with cancer or benign illness.